Journal of Hematology & Thromboembolic Diseases
Open Access

International Conference on Leukemia and Hematologic Oncology

October 17-18, 2016 Rome, Italy

Keynote

• Sequential treatment of AML patients with alvocidib followed by cytarabine and mitoxantrone is highly effective through a mechanism dependent on MCL1 expression and function

  David J Bearss

  PDF HTML